Search research articles
Contact Us
Filters
Showing results (111-120 of 132) with videos related to
Page
of 14
Sort By:
Nature
|
July 9, 2010
Conserved role of intragenic DNA methylation in regulating alternative promoters
Alika K Maunakea, Raman P Nagarajan, Mikhail Bilenky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2024
ECOG-ACRIN EAZ171: Prospective Validation Trial of Germline Predictors of Taxane-Induced Peripheral Neuropathy in Black Women With Early-Stage Breast Cancer
Bryan P Schneider, Fengmin Zhao, Tarah J Ballinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 29, 2020
TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes
Nadine M Tung, Mark E Robson, Steffen Ventz, et al.
Annals of Surgical Oncology
|
October 2, 2009
Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma
L W T Alkureishi, Z Burak, J A Alvarez, et al.
JCO Oncology Practice
|
July 19, 2024
Subcutaneous vs Intravenous Trastuzumab/Pertuzumab: A Time and Motion Substudy of a Phase II Trial of Adjuvant Trastuzumab/Pertuzumab for Stage I HER2+ Breast Cancer (ADEPT trial)
Adrienne G Waks, Emily L Chen, Noah Graham, et al.
Cancer Research Communications
|
April 30, 2024
Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer
Elizabeth C Wescott, Xiaopeng Sun, Paula Gonzalez-Ericsson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 15, 2021
BRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breast Cancer
Bryan P Schneider, Guanglong Jiang, Tarah J Ballinger, et al.
JAMA Oncology
|
July 10, 2020
Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial
Milan Radovich, Guanglong Jiang, Bradley A Hancock, et al.
Contemporary Clinical Trials
|
May 4, 2024
Making Informed Choices On Incorporating Chemoprevention into carE (MiCHOICE, SWOG 1904): Design and methods of a cluster randomized controlled trial
K D Crew, G L Anderson, K B Arnold, et al.
BMC Medical Informatics and Decision Making
|
September 28, 2024
Use of web-based decision support to improve informed choice for chemoprevention: a qualitative analysis of pre-implementation interviews (SWOG S1904)
Alissa M Michel, Haeseung Yi, Jacquelyn Amenta, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 132) with videos related to
Sort By:
Page
of 14
Nature
|
July 9, 2010
Conserved role of intragenic DNA methylation in regulating alternative promoters
Alika K Maunakea, Raman P Nagarajan, Mikhail Bilenky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2024
ECOG-ACRIN EAZ171: Prospective Validation Trial of Germline Predictors of Taxane-Induced Peripheral Neuropathy in Black Women With Early-Stage Breast Cancer
Bryan P Schneider, Fengmin Zhao, Tarah J Ballinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 29, 2020
TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes
Nadine M Tung, Mark E Robson, Steffen Ventz, et al.
Annals of Surgical Oncology
|
October 2, 2009
Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma
L W T Alkureishi, Z Burak, J A Alvarez, et al.
JCO Oncology Practice
|
July 19, 2024
Subcutaneous vs Intravenous Trastuzumab/Pertuzumab: A Time and Motion Substudy of a Phase II Trial of Adjuvant Trastuzumab/Pertuzumab for Stage I HER2+ Breast Cancer (ADEPT trial)
Adrienne G Waks, Emily L Chen, Noah Graham, et al.
Cancer Research Communications
|
April 30, 2024
Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer
Elizabeth C Wescott, Xiaopeng Sun, Paula Gonzalez-Ericsson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 15, 2021
BRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breast Cancer
Bryan P Schneider, Guanglong Jiang, Tarah J Ballinger, et al.
JAMA Oncology
|
July 10, 2020
Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial
Milan Radovich, Guanglong Jiang, Bradley A Hancock, et al.
Contemporary Clinical Trials
|
May 4, 2024
Making Informed Choices On Incorporating Chemoprevention into carE (MiCHOICE, SWOG 1904): Design and methods of a cluster randomized controlled trial
K D Crew, G L Anderson, K B Arnold, et al.
BMC Medical Informatics and Decision Making
|
September 28, 2024
Use of web-based decision support to improve informed choice for chemoprevention: a qualitative analysis of pre-implementation interviews (SWOG S1904)
Alissa M Michel, Haeseung Yi, Jacquelyn Amenta, et al.
Page
of 14